Question 1

What specific symptoms of my asthma could this treatment help with?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

Question 2

How does nebulized IVX-0142 compare to my current asthma medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience worsening asthma symptoms during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I would need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma clinical trial (NCT00232999). Contact the study team or your healthcare provider for specific answers.

What this study is about